- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 5/12 - Peptides cycliques
Détention brevets de la classe C07K 5/12
Brevets de cette classe: 353
Historique des publications depuis 10 ans
21
|
29
|
26
|
19
|
27
|
27
|
21
|
16
|
18
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
University of Florida Research Foundation, Inc. | 3952 |
12 |
The University of British Columbia | 1465 |
10 |
Suntory Holdings Limited | 1968 |
9 |
University of Kansas | 859 |
7 |
Novmetapharma Co., Ltd. | 68 |
7 |
Merck Sharp & Dohme LLC | 3744 |
7 |
Centre National de La Recherche Scientifique | 10068 |
6 |
Enanta Pharmaceuticals, Inc. | 421 |
6 |
Bristol-myers Squibb Company | 4883 |
5 |
The Regents of the University of California | 19493 |
5 |
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A. | 82 |
5 |
Merck & Co., Inc. | 447 |
4 |
Boehringer Ingelheim International GmbH | 4756 |
4 |
The Regents of the University of Michigan | 4570 |
4 |
Celgene Corporation | 1475 |
4 |
Chugai Seiyaku Kabushiki Kaisha | 1315 |
4 |
Mimetogen Pharmaceuticals, Inc. | 18 |
4 |
Promis Neurosciences Inc. | 33 |
4 |
Yeda Research and Development Co. Ltd. | 1304 |
4 |
Massachusetts Institute of Technology | 9909 |
3 |
Autres propriétaires | 239 |